Survival Impact of Surgical Cytoreduction in Stage IV Epithelial Ovarian Cancer

Author： Bristow R.E.   Montz F.J.   Lagasse L.D.   Leuchter R.S.   Karlan B.Y.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.72, Iss.3, 1999-03, pp. : 278-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is There a Role for Surgical Cytoreduction in Stage IV Endometrial Cancer?

By Munkarah A.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 83-84

Elsevier

Access to resources Recommend Favorite

Effect of Surgical Debulking on Survival in Stage IV Ovarian Cancer

By Liu P.C.   Benjamin I.   Morgan M.A.   King S.A.   Mikuta J.J.   Rubin S.C.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 4-8

Elsevier

Access to resources Recommend Favorite

Clinical Outcome of Tertiary Surgical Cytoreduction in Patients with Recurrent Epithelial Ovarian Cancer

By Fotopoulou Christina  

Annals of Surgical Oncology, Vol. 18, Iss. 1, 2011-01 ,pp. : 49-57

Springer Publishing Company

Access to resources Recommend Favorite

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube and primary peritoneal cancer: a change in surgical approach

By  

The Women's Oncology Review, Vol. 4, Iss. 4, 2004-12 ,pp. : 263-264

Informa Healthcare

Access to resources Recommend Favorite

Stage IV Ovarian Cancer: Impact of Surgical Debulking 1

By Curtin J.P.   Malik R.   Venkatraman E.S.   Barakat R.R.   Hoskins W.J.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 9-12

Elsevier

Access to resources Recommend Favorite